Loading...
Tyrosine Kinase Inhibitors as a New Therapy for Ischemic Stroke and other Neurologic Diseases: Is there any Hope for a Better Outcome?
The relevance of tyrosine kinase inhibitors (TKIs) in the treatment of malignancies has been already defined. Aberrant activation of tyrosine kinase signaling pathways has been causally linked not only to cancers but also to other non-oncological diseases. This review concentrates on the novel plaus...
Saved in:
| Published in: | Curr Neuropharmacol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Bentham Science Publishers
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4759323/ https://ncbi.nlm.nih.gov/pubmed/26630962 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X13666150518235504 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|